⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20929389 | 1.00 | — | — | |
| SCHEMBL28071241 | 0.77 | — | — | |
| SCHEMBL799862 | 0.76 | NCF1 (0.30) | — | |
| SCHEMBL25688121 | 0.74 | — | — | |
| SCHEMBL14156565 | 0.73 | CHRNB2 (0.34) | — | |
| SCHEMBL25714594 | 0.72 | — | — | |
| SCHEMBL21658538 | 0.72 | — | — | |
| SCHEMBL18598711 | 0.71 | NPSR1 (0.36) | — | |
| SCHEMBL7273095 | 0.69 | — | — | |
| SCHEMBL14019470 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12441823-B2 | Resin composition for optical shaping | KURARAY NORITAKE DENTAL INC. (JP) | 2025-10-14 | — | — | US | disclosed |
| WO-2025126917-A1 | DENTAL COMPOSITION | クラレノリタケデンタル株式会社 | 2025-06-19 | — | — | WO | disclosed |
| EP-3900693-B1 | USE OF A RESIN COMPOSITION | KURARAY NORITAKE DENTAL INC (JP) | 2024-03-20 | — | — | EP | disclosed |
| US-20220041777-A1 | RESIN COMPOSITION FOR OPTICAL SHAPING | KURARAY NORITAKE DENTAL INC. (JP) | 2022-02-10 | — | — | US | disclosed |
| EP-3900693-A1 | RESIN COMPOSITION FOR OPTICAL MOLDING | Kuraray Noritake Dental Inc. (JP) | 2021-10-27 | — | — | EP | disclosed |
| CN-113226247-A | Resin composition for stereolithography | 可乐丽则武齿科株式会社 | 2021-08-06 | — | — | CN | disclosed |
| WO-2020129736-A1 | RESIN COMPOSITION FOR OPTICAL MOLDING | クラレノリタケデンタル株式会社 | 2020-06-25 | — | — | WO | disclosed |
| US-20170136007-A1 | NOVEL PIPERAZINES, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF | THE FEINSTEIN INST MEDICAL RES (US) | 2017-05-18 | — | — | US | disclosed |
| US-9428522-B2 | Piperazines, pharmaceutical compositions and methods of use thereof | THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH (US) | 2016-08-30 | — | — | US | disclosed |
| US-20140343059-A1 | NOVEL PIPERAZINES, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 2014-11-20 | — | — | US | disclosed |
| US-8822472-B2 | Piperazines, pharmaceutical compositions and methods of use thereof | CORNERSTONE THERAPEUTICS, INC. (US) | 2014-09-02 | — | — | US | disclosed |
| US-20120071652-A1 | Novel Piperazines, Pharmaceutical Compositions and Methods of Use Thereof | CORNERSTONE THERAPEUTICS, INC. (US) | 2012-03-22 | — | — | US | disclosed |
| US-7943622-B2 | Piperazines, pharmaceutical compositions and methods of use thereof | CORNERSTONE THERAPEUTICS, INC. (US) | 2011-05-17 | — | — | US | disclosed |
| US-20080051415-A1 | Novel piperazines, pharmaceutical compositions and methods of use thereof | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 2008-02-28 | — | — | US | disclosed |